Skip to main content

Table 4 Annualized total costs by inhibitor status (€; Euros)

From: Costs and utilization of treatment in patients with hemophilia

 

Total cost

P-value

With inhibitor (n = 5)

134,032

0.030

Without inhibitor (n = 98)

40,318

 
  1. P value was computed using the Mann-Whitney U test